The House of Representatives voted 344-77 for a bill that would boost federal funding for medical research, and would speed up Food and Drug Administration approvals for many new drugs […]
Featured Posts
BOSTON, MA–(Marketwired – Jul 9, 2015) – Vaccine products in the R&D pipeline have more than tripled since 2005 and annual worldwide sales are on track to reach $40 billion […]
It used to be that the major hurdle in getting a new drug approved was successfully completing phase 3 trials – the long-term studies needed to prove to regulators that […]
“Shark Week,” the insanely popular week-long festival of flesh-ripping, terror-inducing finned creatures, is in full-swing on the Discovery Channel and no doubt will be just as popular as ever in […]
CHICAGO, IL and LA JOLLA, CA–(Marketwired – Jul 1, 2015) – Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the acquisition and development of enhanced therapeutics for […]
On his first day as chief executive of Ligand Pharmaceuticals in January 2007, John Higgins was shown into a conference room in the biotech firm’s 135,000-square-foot San Diego headquarters. Inside […]
Korea’s startup landscape remains partial to gaming. Demand has been growing at such a staggering clip that the industry now accounts for 90% of the country’s mobile app revenues. The […]
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–CureDuchenne today applauded the U.S. Food and Drug Administration (FDA), which took the critical step of accepting the first-ever New Drug Application (NDA) for a possible treatment […]
Results from an extensive new study suggest that early symptoms of Alzheimer’s disease appear up to 18 years before the disease is officially diagnosed. Researchers publishing in the journal Neurology […]
External models of R&D innovation are the rage in Pharma today, as they should be – the future of our industry depends on a great deal more rather than less […]